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The NHS Bowel Cancer Screening Programme (BCSP) is aimed at reducing colorectal cancer (CRC) mortality through early
detection within a healthy population. This study explores how 5 people (three females) experience and make sense of their
screen-detected diagnosis and the psychological implications of this diagnostic pathway. A biographical narrative interview
method was used, and transcripts were analysed using a thematic analysis with a phenomenological lens. Themes speciﬁcally
relating to posttreatment experience and reﬂections are reported here: Do it: being living proof, Resisting the threat of
recurrence, Rationalising bodily change, and Continuing life—“carrying on normally.” Participants described their gratefulness
to the BCSP, motivating a strong desire to persuade others to be screened. Furthermore, participants professed a duality of
experience categorised by the normalisation of life after diagnosis and treatment and an identiﬁcation of strength post cancer, as
well as a diﬃculty adjusting to the new changes in life and a contrasting identity of frailty. Understanding both the long- and
short-term impacts of a CRC diagnosis through screening is instrumental to the optimisation of support for patients. The results
perhaps highlight a particular target for psychological distress reduction, which could reduce the direct and indirect cost of
cancer to the patient.
1. Introduction
Colorectal cancer (CRC) is the second most common cause
of cancer death in the UK; nevertheless, it is also one of the
most treatable cancers if detected early [1–3]. In 2006, the
English National Health Service (NHS) introduced a
population-based screening programme to help reduce
CRC mortality. The Bowel Cancer Screening Programme
(BCSP) invites men and women aged 60–74, and registered
with a general practice in England, to complete a guaiac fae-
cal occult blood test (gFOBt) at home, every two years. The
gFOBt involves the individual collecting small samples of
their faeces from three separate bowel movements and send-
ing the completed test kit to their local screening hub, where
the samples are tested for traces of blood. Blood in a stool
sample could be a sign of bowel cancer and so, if present, a
follow-up endoscopic test (i.e., colonoscopy) is oﬀered to
determine the cause of the bleed and to initiate the necessary
treatment [4]. A Cochrane review by Hewitson and col-
leagues found that taking part in gFOBt screening can reduce
CRC mortality by up to 25% [5].
Uptake of the BCSP is a major public health concern with
only 59% of eligible invitees completing and returning a
gFOBt [6]. Much research has focused on identifying the psy-
chological and practical barriers to test completion, so as to
understand the reasons for non-participation and to tailor
interventions accordingly. Reasons for non-test completion
include a fear of cancer and feeling healthy at the time of
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the screening invitation, or having a belief that the process of
the test (e.g., sampling faeces and storing faecal samples) was
unsanitary or embarrassing [7–10].
There has been additional interest in the psychological
impact of CRC screening participation (from receiving the
invitation and test materials in the post to receiving an
abnormal test result) with predominantly quantitative stud-
ies conducted and a negative impact only found in the short
term [11–16]. What remains missing from the literature is a
qualitative exploration of the impact of being diagnosed with
screen-detected CRC.
Qualitative research is available that explores the experi-
ence and impact of investigative tests via the NHS referral
process in England [17, 18]. Both studies interviewed patients
who were referred via their general practitioner (GP) or
through the accident and emergency department when
CRC was suspected, and both indicated a period of height-
ened anxiety and a need for more information within this
pathway to help reduce fears and uncertainty at this time.
Individuals interviewed within Worster and Holmes’ study
had been diagnosed with CRC and had recently received
therapeutic surgery [17]. Further analysis of their interviews
included themes of continued fear and anxiety at the realisa-
tion of their cancer diagnosis and prognosis [19]. Unlike
CRC screening, patients are referred for tests after presenting
with symptoms and so their experience may be diﬀerent to
those tested and then diagnosed as part of a screening path-
way, particularly given the eﬀectiveness of the BCSP and
the focus on early detection.
While we do not know how a diagnosis initiated through
completion of the gFOBt impacts individuals, interesting
work has been done in the UK using an alternative screening
methodology. Miles and colleagues conducted an interview
study with 24 people diagnosed with CRC following partici-
pation in a trial using ﬂexible sigmoidoscopy (FS) as a screen-
ing procedure [20]. Thematic analysis of the interview
transcripts indicated a general feeling of shock following
the diagnosis, which was an unexpected outcome given a lack
of perceived symptoms. Interviewees had taken part in
screening as a way to reassure themselves of their good health
as opposed to being a means of conﬁrming disease. Their ini-
tial reaction was one of fear, which was later diﬀused by an
understanding and appreciation that the screening had
caught the cancer at an early, treatable stage.
A review by Aziz concluded a need for further research
into cancer survivorship by suggesting that individuals expe-
rience positive and negative acute and long-term eﬀects of
cancer (psychological, physiological, and social), which occur
as a direct response of a cancer diagnosis [21]. Such eﬀects
can include identity reconstruction and an integration of
the cancer experience into one’s self-concept [22] and how
one views themselves and their body [23]. There is currently
no research considering cancer survivorship speciﬁcally in
relation to patients diagnosed through the UK screening pro-
gramme, and yet as the programme continues, more and
more people will be diagnosed early and become such
survivors.
In this study, we aimed to better understand the experi-
ences associated with receiving a cancer diagnosis within
the screening programme, as described by survivors, to iden-
tify their needs and adapt the support that has been provided
to patients diagnosed symptomatically. To do this, we review
the events, descriptions, and reﬂections encased within the
individual, personal stories of those previously diagnosed
with CRC through the NHS BCSP.
2. Materials and Methods
2.1. Study Design. A phenomenological lens was applied to
explore the experiences of participants in an ideographic
and inductive way. This means that we view the screening,
detection, and treatment of cancer as an experiential phe-
nomenon within a broader context of constant social interac-
tions and bodily sensations (the lifeworld) [24]. We also take
as a principle that people are constantly interpreting life post
hoc, both alone and in the interview context.
2.2. Recruitment and Participants. Participants were initially
recruited to take part in a study where the aim was to develop
and evaluate a narrative-based leaﬂet that would help engage
future CRC screening invitees and address some of the key
barriers to uptake (e.g., feeling well) [25, 26]. For the develop-
ment of the leaﬂet, 21 individuals who had previously taken
part in the NHS BCSP were recruited and interviewed about
their screening experience [25]. A CRC diagnosis was not
part of the eligibility criteria; however, for the current study,
only the personal stories of those who were diagnosed with
CRC through the screening programme were considered
for analysis. Although 8 of the 21 interviewees had had a
diagnosis of cancer following screening, only 5 of the inter-
view transcripts were of a depth and quality suitable for anal-
ysis. All 5 interviewees consented for their interviews to be
analysed in this way. Table 1 provides characteristics of the
5 participants whose stories were analysed for this study.
All participants included in this study were recruited via
the UK-based charity, Beating Bowel Cancer (BBC). A
recruitment advertisement for the study was published on
the charity’s website and corresponding Facebook page.
Emails containing details of the study were also sent directly
from a BBC representative to charity members known to
have been diagnosed with CRC through the NHS BCSP. All
interested individuals were asked to contact the researcher
(LM) to conﬁrm their interest and discuss possible participa-
tion. A patient information sheet and consent form were sent
to those interested, for further consideration, with a subse-
quent telephone call conﬁrming receipt, and, where relevant,
the date and time for the interview was arranged.
2.3. Procedure. All interviews were conducted in a venue and
format convenient for the participant: home interview via
telephone (n = 4) and face-to-face interview within the uni-
versity (n = 1). The author LM conducted all interviews
except one telephone interview, which was carried out by a
trained MSc Health Psychology student. Telephone inter-
views have been identiﬁed as a successful alternative to
face-to-face interviews, particularly where sensitive topics
are included, and the participants would otherwise not be
included for geographical reasons [27].
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Interviews were conducted following a narrative inter-
view design that is aimed at allowing events and thoughts
to be described in the participants’ own words and in the
order that came most naturally to them. The interview design
had 3 stages. The ﬁrst involved the following “Single Ques-
tion aimed at Inducing Narrative” (SQUIN) [28]:
Can you please tell me your story of how you came to do
the bowel cancer screening test kit and how it all turned out?
Tell me the events and experiences which were important for
you. Begin wherever you like. Take all the time you need.
The participant’s response to this question was uninter-
rupted; only reiterations of the main question and encour-
agement to continue were oﬀered from the interviewer
when necessary. When the participant indicated that they
had come to the end of their story (e.g., “And that is basically
my story.”), the interviewer then proceeded to the next stage
whereby more probing, open questions were asked to gain
further information and clariﬁcation to the initial, relevant
“story” content. These questions were similar to Wengraf’s
“Topic Question aimed at Inducing Narrative” (TQUINs)
and followed the order of the issues and statements made
in the initial story provided so as to follow the participant’s
line of thinking [28]. The ﬁnal stage then involved asking
predetermined questions relevant to the aim of the research
that had not been covered in the ﬁrst two steps, for example,
“What advice would you give someone who has just received
the gFOBt kit in the post?” Interviews lasted between 40 and
120 minutes and were conducted between the 7 October 2011
and 9 November 2011. Ethical approval was granted by Uni-
versity College London’s Research Ethics Committee (letter
dated 20 June 2011).
2.4. Data Analysis. A thematic analysis was applied to the
interview transcripts [29, 30]. First, each transcript was read
several times for familiarity and annotated. Sections of the
text were highlighted and labelled in a free coding process,
with codes pertaining to a participant’s meanings and experi-
ences. Once this process had been completed for each partic-
ipant, codes were analysed between and across cases and
developed into interpretative themes.
2.5. Quality Assurance. Prior to analysis, interviews were
audio-recorded and transcribed verbatim. Each participant
was oﬀered the opportunity to proofread their transcript in
order to conﬁrm the content. Only two were returned with
minor grammatical changes or “unclear” words completed;
no substantial changes to the content were made. The ﬁnal
transcripts were then analysed (led by GB with the support
from LM and ST). To ensure quality and rigour of the analy-
sis, the themes were revised by iterations of analysis with the
transcriptions and repeated discussions with the other
authors during the initial thematisation and interpretative
thematic processes. Themes were reorganised and renamed
to ensure appropriate representation of the data, and a his-
torical paper trail was kept detailing all stages of the analysis.
3. Results
A number of themes were identiﬁed from the narratives ana-
lysed that have not been reported here, including “shock at
the diagnosis” and “a need to regain control of the situation
at the point of diagnosis,”mirroring those found in an earlier
study [20]. For this article, we have elected to report on the
themes found in relation to the current position of survivor-
ship due to the gap in the literature on this topic. Our analysis
identiﬁed four themes: Do it: being living proof, Resisting the
threat of recurrence, Rationalising bodily change, and Con-
tinuing life—“carrying on normally.” Together, these themes
describe how participants now make sense of their cancer
diagnosis and have adjusted to life afterwards.
3.1. Do It: Being Living Proof. Having experienced the initial
shock of diagnosis, participants expressed passionate feelings
about gFOBt completion, considering it to be something
which had saved their lives: this we understood from their
primary expression of feeling “lucky.” They felt highly moti-
vated to persuade other people to carry out the test. We will
start with Simon who espouses this idea most fully. As a pro-
active bowel cancer charity member and a conﬁdent speaker,
this quote illustrates his fervent appreciation for what the
gFOBt did for him and the necessity of blindly complying
with it:
For me, if you get the kit it’s a no brainer, don’t even think
about, just do it. […] I consider myself to be very lucky and
that decision I made to complete that screening kit in Decem-
ber 2008 was probably the best decision I’ve ever made in my
life. (Simon)
Simon is persuading us with two notions that the evi-
dence surpasses criticism (a “no brainer”) and, furthermore,
that he is lucky to have been diagnosed with cancer through
screening. Other participants echoed these feelings, particu-
larly seeing the test as something which would catch cancer
early and accurately. Bill oﬀers a scientiﬁc basis for taking
part—the test is accurate, and the test will see if there is
“something there.”
Do it, do it. I mean, you know, it, it could save your life.
You’re stupid, if you don’t… Do it. Erm, because it’s an oppor-
tunity, it’s an opportunity that people 20 years ago didn’t have.
You are now being given the opportunity to check once and for
all, ‘cause it is pretty accurate, check once and for all that erm,
at least there is something there. (Bill)
So again we witness the emphasis on luck, this time
expressed as fortunate “opportunity,” and an implied criti-
cism of people who might choose not to take the test. Again,
based on the inherent righteousness of their own near miss,
Table 1: Participant characteristics.
Participant
(pseudonym)
Gender
Age at the
time of
interview
Marital
status
Time since
diagnosis (in
years)
Simon Male 68 Married 3
Celia Female 64 Widowed 4
Bill Male 73 Married 11
Helen Female 63 Married 1
Pauline Female 71 Married 2
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Celia and Bill are incredulous. To avoid the test would be
“silly” or “stupid”:
So I mean I think if anybody had the test and didn’t do it I
think they’re very silly. You know erm, because even if you go
oh that’s not going to happen to me and erm, you know, and it
could do, as I proved. (Celia)
Like Simon, Pauline felt the need to persuade others to
take the test without consideration, information, or hesita-
tion and to believe in the rightness of doing so.
Get on with it. Don’t eh, this is... I’m being very naughty
here. Don’t… Just, just do it. In your time do it, but make sure
you do it within the time you need to have done it and send it
oﬀ and say some prayers, you know, or ... but make sure you
get it done and sent oﬀ. (Pauline)
Another persuasive force in the imperative to persuade
others is expressed as “catching it early.” Helen uses her
own example, despite being diagnosed with secondary
tumours:
So I said “You do it”, and I got onto everybody now that I
know, do the test whenever you get it because the importance
of catching it early. I mean I caught mine really as early as,
you know, the gaps between the tests and yet it has spread to
my lymph nodes and it has gone to my lung, so if I hadn’t have
done that test and I’d have just left it, it could have been too
late, you know, and so if everybody does the test as soon as they
get it they’ve got a much better chance… (Helen)
Helen is so enthused here that she wants to impart her
new wisdom to “everybody now.” Simon and Helen both
make sense of their own cancer diagnosis as direct proof of
the need for others to follow their example:
I’d tell them for Christ’s sake do it, based on my own expe-
rience (Simon)
I just say to people ‘Do it’, the National Health are not
sending it out for fun, it’s for your beneﬁt, and my boss, my
ex-boss, actually had afternoon tea with him yesterday, we’re
still in touch, he said he’d never done it, he said “I didn’t like
the thought of doing it”, he said, “But now I’ve heard your
story” he said “I’d do it”. (Helen)
All participants are mindful of their own luck in being
diagnosed and express a desire to rebalance their good for-
tune and give something back by persuading others to partic-
ipate in the screening.
3.2. Resisting the Threat of Recurrence. Having been diag-
nosed with cancer when they were ostensibly symptom-free
had created a feeling of unease and distrust in bodily symp-
toms. The potential for, or reality of, cancer recurrence dom-
inated their thinking, and yet they wanted to break free from
it and be “positive.” Pauline tried to manage her fears about
watching and waiting but admitted she did think about it:
People are still aware, if you’ve had cancer, it’s still around
[…] I don’t know whether it’s, it’s not what you should think,
but it’s, you know, you should get on with what you’ve got to
get on with, really, and [Mmm] as far as I’m concerned at
the moment. I, I can’t say I don’t think about eh, if it’s still
lurking around, but [Mmm] I, I don’t think we’ve got to think
about it. I think we’ve got to be positive. (Pauline)
Simon was additionally diagnosed with prostate cancer
during investigations for his colorectal cancer and has to
undergo regular testing. Still, he was able to dwell on the lack
of bone metastases as a reason to stay positive:
…but even on the prostate I’m only being seen every three
months, prostate cancer normally goes to your bones. I’ve
recently had a full body bone scan and I’m perfectly clear, so
I guess that’s me and now leading the same active life that I
had before…
Part of staying positive was to illuminate the unknown by
having further tests and then “dealing with it,” suggesting
that whatever the test revealed was less frightening than the
imagined horror of the creeping and lurking disease. Testing
had particular power as a way of knowing what was happen-
ing inside but also imposed a timeframe within the contin-
uum of existence. The only ally against the unknown inside
the body was a CT or MRI scan—time between scans was
deﬁned as “waiting.” Celia was the main proponent of this
idea:
I tell everybody at work, I just live 6 months at a time. I
have the scan, they tell me I’m okay so therefore I know I’ve
got, I should be alive for the next 6 months, end of. (Celia)
Celia is no longer able to imagine being “okay” beyond
the 6-month timeframe between tests. She has lost the ability
to “detect” her own wellness and is left dependent upon
machines and tests to provide her with a future.
3.3. Rationalising Bodily Change. Part of the new horizon of
life after diagnosis and treatment for all cancer patients is
the adjustment to changes in one’s body and the way in
which they perceive their illness in relation to their new
embodied self. We also realised that having been screened
from the age of 60, other people of the same age would be
adjusting to various other changes, such as retirement and
physical capabilities. Therefore, diagnosis of cancer through
the screening programme (and related bodily treatment,
recovery, and long-term adjustment) may be related to wider
experiences of change. After being diagnosed through
screening, all participants mentioned that their bodies had
changed, provoking them to isolate and evaluate their bodies
as objects, relative to other potential states, such as the time
before cancer diagnosis or an imagined state of much worse
illness. Helen admitted that she was reluctant to see herself
as frail:
Erm, this was a serious illness and I think just admitting
frailty, which I don’t like doing, {laughs} you know, and I
had to admit that, you know. (Helen)
There was a need to project wellness and normality,
which may be due to societal expectations and media narra-
tives around positive thinking with respect to cancer. Think-
ing about the diﬃcult changes their body had gone through
while trying to project positivity suggests a separation of
body and self. Bill inhabits his body with a feeling of pride,
particularly in relation to medical performance. Throughout
his transcript, he described his body in two ways, with his
“good” body commended for its physical performance in
spite of his “bad,” tired, and ill body. He champions his
response to chemotherapy and blood tests:
I had absolutely no side eﬀects at all apart from err, a taste
of aluminium in my mouth all the time. Erm and the degree, I
suppose a degree of tiredness. So in fact I swanned through
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chemotherapy without any major problems and since then I’ve
met people who’ve had far more problems than me. (Bill)
Other participants were not so much proud as tolerant of
bodily change. Simon was keen to focus on the resumption of
his normal life, going on trips and out to restaurants. This
was then qualiﬁed by the need to take loperamide and to be
“surreptitious” about who he shares a room with in case his
symptoms embarrass him. However, the focus was very
much on returning to life as it was “before,” framing his
desired life in the time before diagnosis:
so erm I guess that’s me and now erm leading the same
active life that I had before, apart from the occasional embar-
rassment with diarrhoea and that sort of thing.. (Simon)
In a more regretful account, Pauline yearns for her body
to resume its pre-cancer form, saying “I just wanted it, again,
I wanted to be like I was before this all started to happen.” Yet
in another extract, we can see that she also wants to adjust:
You, you learn to adjust. You just adjust accordingly,
[Yeah] so it’s eh, em, you know, I can’t sort of dance and do
quite, I can, but not quite [Mmm] so, so much, but, you know,
as you’re getting older it’s less important. What’s important is
that you’re alive and you’re well and you’re able to do a cer-
tain amount of things. This is the thing. (Pauline)
These extracts point to an experience of bodily change
which provokes a consideration of the body as separate to
self. As the body has become less able or changed, partici-
pants evaluate their ability to do everyday activities, espe-
cially those enjoyed before illness. Feelings about bodily
change and bodily performance are evaluated relative to
other known cancer patients, to former activities and abili-
ties, and to the alternative of severe illness and death.
3.4. Continuing Life—“Carrying on Normally.” Linked to the
previous theme about the need to portray and embody posi-
tivity, the participants made sense of being diagnosed with
cancer through screening by using metaphors to show them-
selves to be strong or normal. The ability to continue eﬀec-
tively with life was always related to adopting a well
persona; any worry about frailty or morbidity was rejected
or avoided.
The gravity of cancer as their illness provoked strong
metaphors from the participants about their ways of achiev-
ing a positive outlook. Here, Simon describes the importance
of his granddaughter’s account of him being invincible,
where his cancer is portrayed as a meteorite:
She said “I’m just picturing you granddad”, I said go on,
she said “The world has just been struck by a meteorite, it’s
about to be destroyed and you’re standing on the top of this hill
and you’re looking down on the devastation covered in dust
and you’re dusting yourself oﬀ and saying ‘is that the best
you can throw at me’, and that has stuck with me forever
and I go back to it. (Simon)
The cancer is obviously felt to be an event of overwhelm-
ing might and strength both for the granddaughter and for
Simon in his adherence to her description. Simon is com-
forted by this image of him, banishing his own depressed
feelings and vulnerability. Celia describes a private reaction
to the cancer experience which is expressed as “shouting
and screaming,” but like Simon, she feels that inhabiting
the positive identity does her more good:
I mean I can shout and scream with the best of them, and
that when I’m indoors on my own but it’s not going to do any
good is it. So err, you might as well put a grin on your face and
go out there and live with it. You’ve got it so, you know, deal
with it. (Celia)
Helen seems to be at a diﬀerent point in the process to the
other participants. She recognises herself as a shadow, but
this has as much to do with cancer as with her advancing
age and her retirement:
I just became a shadow of my former self and that was it,
you know, mentally and physically. It was, in a way a sense of
loss, the whole thing, because I left work ﬁnally in the April… I
was also chair of governors at the school and had to give that
up because I knew if I was going to have operations and chemo
and radiotherapy I wouldn’t be able to fulﬁl my duties there.
(Helen)
Despite these feelings, Helen also describes a need for
normality, using the drama of a “howling wind” to exemplify
her resistance and strength:
Erm, it’s changed a bit but, I’m doing, I’m going to a ﬁre-
work party on Friday, I’m starting sorting out things for
Christmas, you know, went down the beach yesterday, despite
the howling wind and everything, and sat behind the shack
and had an ice-cream with the son and the grandchildren,
you know, so, you know, you just carry on normally.
We notice here that “carrying on” and “dealing with it”
are the ultimate goals for these participants. Metaphors for
the might of cancer are used to impress upon us what they
have faced: images of strength are invoked in an eﬀort to nav-
igate a course of uncertainty and emotional diﬃculty, but
they must keep moving.
4. Discussion
The aims of the present study were to explore how people
experience and make sense of their screen-detected diagnosis
of CRC and the psychological implications of this diagnostic
pathway. While participants described their experience from
receipt of the test to their present, posttreatment self, in this
paper, we focused on the novel themes that describe the expe-
riences after treatment.
Cancer survivorship is deﬁned as the acute and long-
term, positive and negative, physical and psychosocial eﬀects
of a cancer diagnosis and treatment [21]. Screening increases
the likelihood of a cancer being found at an early stage and of
survival. Therefore, those diagnosed by screening are likely to
enter into stages of survivorship where eﬀects of the initial
diagnosis can continue long into their lifetime. Previous
research suggested that the extent to which individuals iden-
tify with their cancer experience may be an important aspect
of their adjustment to longer-term cancer survivorship [22,
31] and how one views themselves and their body [23].
For our participants diagnosed via screening, once they
entered into a stage of survivorship, they attempted to
assume the role of the well person, which involved the con-
struction of two diﬀerent identities: a strong, healthy, humor-
ous, and public/social identity, and a diseased, frail,
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embarrassed, and child-like identity. In order to continue
with life after illness and treatment, one had to assume a
new identity, which was diﬀerent from the preillness and ill-
ness identities. Taking on the strong, almost invincible role
was important as it allowed people to “just get on with it.”
Nevertheless, participants acknowledged that often taking
on the new “well role”meant that they felt great loss for their
former identities (e.g., Helen’s loss of her identity as a profes-
sional woman), leaving them a mere “shadow” of their for-
mer selves. Yet despite their diﬃcult transitions,
participants continued on in life, with the belief that one
should “just carry on normally, despite the howling wind
and everything.”
Similar to Miles and colleagues, participants described
feeling shocked at their diagnosis as they believed themselves
to be well [20]. Their pre-screening illness representation
meant that the decision to complete the test was led by a
desire for veriﬁcation of wellness or out of responsibility
and support for the NHS. As time went on, these feelings of
shock were later diﬀused and replaced with unequivocal grat-
itude for the opportunity to catch the cancer early and to
reach a stage of “survivorship.” Given this context and
despite the identity adjustment described above, participants
seem to be driven to encourage others to do the same with the
message that they too can “catch it early” and be saved. To
date, research has not looked at the relationship between
screen-detected CRC diagnoses or survivorship and attitudes
toward (public promotion of) related screening services. This
is important given the survivor’s narratives surrounding
screening in the public sphere and knowing that someone
with cancer can often inﬂuence the decision of others invited
to take part in screening [8, 32]. Future work to further
explore the underlying motivations for the almost evangelical
promotion of CRC screening by survivors, as highlighted in
this study, and how it compares to those with other screen-
detected cancers (i.e., breast or cervical) and those who were
diagnosed with CRC out with screening, would also be bene-
ﬁcial to inform interventions for either survivorship support
or screening promotion.
Participants expressed simultaneously contradictory
emotional responses to their diagnosis and the continued
retesting for cancer, suggesting that they experienced both
fear and relief at multiple stages throughout their adjustment
to life after diagnosis and treatment. This adjustment
included the formation of a new relationship with their bod-
ies, one which incorporated dual identities of an embodied
strength and resilience as well as frailty and constant reap-
praisal of their health and adjustment to the new norms of
their body. Chronic health issues experienced as a result of
cancer treatment facilitated a feeling of unease and mis-
trust of one’s body. Participants described this mistrust
of their body and a mistrust of their ability to assess their
own health when they expressed the conﬂict over
experiencing a body that previously felt well [8] but was
actually inhabited by an “insidious cancer that crept
within.” Their new embodied experiences include assimila-
tion of the new and embarrassing symptoms, admittance
of weakness, and creation of a new deﬁnition of what is
“normal” for their changed bodies.
While much of the current literature in the area has
focused on identifying the psychological and practical bar-
riers to test completion [7–10, 33] and the psychological
impact of CRC screening in general [11–16], most studies
have been quantitative in nature and have not looked into
the experience of and psychological impact of screening-
detected CRC diagnosis in a longer term. This paper there-
fore oﬀers an important addition to the literature to date,
allowing an insight into the long-term consequences of a
screen-detected CRC diagnosis. Future work could consider
comparisons with those who reach a similar stage following
a CRC diagnosis from symptomatic or emergency presenta-
tion to allow a more multidimensional understanding of
CRC survivorship. Indeed, in a recent quantitative survey
study, diﬀerences in patient-reported care experience were
noted between those diagnosed across various pathways;
screen-diagnosed patients were less likely to report negative
experiences than those diagnosed through emergency pre-
sentation [34]. Therefore, important diﬀerences may also be
apparent after treatment and have implications for support
through survivorship. In line with the common sense model
[35], by understanding how colorectal cancer survivors make
sense of their illness experience and current health status and
manage future health threats, we are in a better position to
support those who receive a screen diagnosis of colorectal
cancer and enter an ongoing period of survivorship.
4.1. Limitations. Each interview describes a retrospective
account of the individual’s bowel cancer screening experi-
ence and could therefore be considered vulnerable to recall
error and biased sampling. However, the biographical narra-
tive interview method used encouraged a rich account of the
subjective experience of receiving a diagnosis of cancer via
screening, and therefore the focus is on participants’ subjec-
tive experience rather than on accurate recall of events [28].
Furthermore, the phenomenological approach encourages a
small and purposive sampling technique to enable in-depth
idiographic analysis of interview data.
Limitations existed within the study sample, including
heterogeneity of the sample which included participants in
varying stages of their recovery (ranging from 1 to 11 years
postdiagnosis). Nevertheless, all participants experienced sig-
niﬁcant changes in identity and were able to vividly recollect
the memorable experience of diagnosis and what this meant
to them and continues to mean to them in life postdiagnosis.
Furthermore, it should be acknowledged that people with
other screen-detected cancers may experience similar reac-
tions to their diagnosis, changes in identity, and general
adjustments to life posttreatment; however, this was not a
comparative but rather an explorative study and, therefore,
conclusions can only be representative of the participants of
this study. Furthermore, it is important to note that partici-
pants were recruited for the main purpose of providing their
personal story of screening to help in the development of a
narrative-based leaﬂet to supplement current information
provided to CRC screening invitees and were members of
the Beating Bowel Cancer (BBC) charity. Therefore, the sam-
ple was limited to people who had, to some degree, sought
6 Gastroenterology Research and Practice
support from a charity network and were motivated to help
increase uptake of the current screening programme.
5. Conclusion
This phenomenological study of ﬁve individuals diagnosed
with colorectal cancer via the NHS BCSP has highlighted
key psychological implications of screening.
A screened-detected cancer is often detected and treated
at an early stage, suggesting greater chance of survival. There-
fore, people who chose screening are likely surviving longer
after cancer than those diagnosed following symptomatic
presentation. Understanding the long-term impact of a
screen-detected diagnosis is instrumental to the optimisation
of patient support through treatment and beyond. The com-
plexity of the survivorship experience highlights the need for
healthcare professionals to be aware that there is the potential
for distress and anxiety even in periods of remission and that
patient may need support to ﬁnd ways forward. Future work
could more directly consider comparisons with individuals in
a post-treatment phase following a symptomatic diagnosis to
assess if and when diﬀerent supports are needed across the
two patient groups.
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